204 related articles for article (PubMed ID: 33811701)
1. Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors.
Bonandi E; Mori M; Infante P; Basili I; Di Marcotullio L; Calcaterra A; Catti F; Botta B; Passarella D
Chemistry; 2021 Jun; 27(32):8350-8357. PubMed ID: 33811701
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
3. Biology-oriented synthesis of a withanolide-inspired compound collection reveals novel modulators of hedgehog signaling.
Švenda J; Sheremet M; Kremer L; Maier L; Bauer JO; Strohmann C; Ziegler S; Kumar K; Waldmann H
Angew Chem Int Ed Engl; 2015 May; 54(19):5596-602. PubMed ID: 25736574
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides.
Singh A; Raza A; Amin S; Damodaran C; Sharma AK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164150
[TBL] [Abstract][Full Text] [Related]
5. Withanolides: Promising candidates for cancer therapy.
Zhang Q; Yuan Y; Cao S; Kang N; Qiu F
Phytother Res; 2024 Feb; 38(2):1104-1158. PubMed ID: 38176694
[TBL] [Abstract][Full Text] [Related]
6. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A; Shandilya A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798
[TBL] [Abstract][Full Text] [Related]
7. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
8. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
10. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
11. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
12. The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma.
Jain R; Dubey SK; Singhvi G
Drug Discov Today; 2022 Apr; 27(4):1176-1183. PubMed ID: 34896624
[TBL] [Abstract][Full Text] [Related]
13. Natural Products Inspired Modulators of Cancer Stem Cells-specific Signaling Pathways Notch and Hedgehog.
Palermo R; Ghirga F; Piccioni MG; Bernardi F; Zhdanovskaya N; Infante P; Mori M
Curr Pharm Des; 2018; 24(36):4251-4269. PubMed ID: 30636589
[TBL] [Abstract][Full Text] [Related]
14. Design of Hedgehog pathway inhibitors for cancer treatment.
Bariwal J; Kumar V; Dong Y; Mahato RI
Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872
[TBL] [Abstract][Full Text] [Related]
15. TFA-mediated stereoselective aza-Michael addition for the synthesis of 3β-arylamine derivatives of withaferin A and evaluation of their anticancer potential.
Mir SA; Wani RA; Maqbool MS; Singh D; Bharitkar YP; Malik FA; Yousuf SK
Steroids; 2023 Mar; 191():109172. PubMed ID: 36574871
[TBL] [Abstract][Full Text] [Related]
16. Withaferin A activates stress signalling proteins in high risk acute lymphoblastic leukemia.
Shi LH; Wu XJ; Liu JS; Gao YB
Int J Clin Exp Pathol; 2015; 8(12):15652-60. PubMed ID: 26884834
[TBL] [Abstract][Full Text] [Related]
17. Molecular insight in the multifunctional activities of Withaferin A.
Vanden Berghe W; Sabbe L; Kaileh M; Haegeman G; Heyninck K
Biochem Pharmacol; 2012 Nov; 84(10):1282-91. PubMed ID: 22981382
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy.
Mayank ; Jaitak V
Comput Biol Chem; 2016 Jun; 62():145-54. PubMed ID: 26278973
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog inhibitors: a patent review (2013 - present).
Xin M
Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
[TBL] [Abstract][Full Text] [Related]
20. Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway.
Liu X; Li Y; Ma Q; Wang Y; Song AL
Med Sci Monit; 2019 Sep; 25():6855-6863. PubMed ID: 31512681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
